PreveCeutical Medical Inc.
CNQ: PREV.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stephen Van Deventer
- Headquarters
- Vancouver, Canada
- IPO year
- 2017
- Market cap
- CA$11.7M
- Website
- https://www.preveceutical.com
Loading PREV…
Loading profile data…Frequently asked questions about PREV
What does PreveCeutical Medical Inc. (PREV.CN) do?
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including...
Where does PREV.CN trade?
PreveCeutical Medical Inc. (PREV.CN) trades on the Canadian Securities Exchange.
What sector is PREV.CN in?
PreveCeutical Medical Inc. (PREV.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PreveCeutical Medical Inc.?
Stephen Van Deventer is the chief executive officer of PreveCeutical Medical Inc. (PREV.CN).
Where is PreveCeutical Medical Inc. headquartered?
PreveCeutical Medical Inc. is headquartered in Canada.
Does PREV.CN pay a dividend?
PreveCeutical Medical Inc. (PREV.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PREV.CN go public?
PreveCeutical Medical Inc. (PREV.CN) completed its initial public offering in 2017.